s10920
NM_021003.4
NM_177951.2
NM_177952.2
XM_005267779.1
XM_005267781.1
XM_011536872.1
XM_011536876.1
XM_011536877.1
XM_011536878.1
XM_011536879.2
XM_011536880.2
XM_011536881.2
XM_011536882.2
XM_011536883.1
XM_011536884.1
XM_017021381.1
XM_017021382.1
XM_017021383.1
XM_017021384.1
XM_017021385.1
XM_017021386.1
XM_017021387.1
14%(+/-2% mRNA remaining)(HeLa cell line) [TaqMan® Assay ID: Hs00221372_m1]
HeLa cells were reverse transfected with 5nM gene-specific Silencer® Select siRNA or 5nM Silencer® Select Negative Control #2 siRNA. 48 hours post-transfection, gene expression analysis was performed using the TaqMan® Gene Expression Cells-to-CT Kit and appropriate TaqMan® Gene Expression Assays. 18S rRNA was used as an endogenous control. Validation results are expressed as average percent mRNA remaining, relative to Negative Control siRNA-treated samples, along with the standard deviation of multiple independent experiments.